European Neuropsychopharmacology

SEP 21, 2026 · JOURNAL ARTICLE

5. BRIDGING THE POPULATION DIVERSITY GAPS IN PSYCHIATRY GENOMICS AND BIOLOGY: FINDINGS FROM A FAMILY BASED COHORT STUDY FROM INDIA

European Neuropsychopharmacology

Background Major psychiatric illnesses are highly heritable, yet the search for replicable genetic and neurobiological mechanisms has proven highly challenging. One of the major re

SEP 21, 2026 · REVIEW

W66. TRANS-ANCESTRY AND SEX-STRATIFIED GENOME-WIDE ASSOCIATION META-ANALYSIS OF MAJOR DEPRESSIVE DISORDER DIAGNOSIS IN 500,000 CASES AND 2 MILLION CONTROLS

European Neuropsychopharmacology

Background Large-scale genome-wide association studies (GWASs) have accelerated genomic discovery for major depressive disorder (MDD), but important limitations persist. To date, m

SEP 21, 2026 · JOURNAL ARTICLE

GENOME-WIDE ASSOCIATION STUDIES OF NON-RESPONSE TO ANTIDEPRESSANTS LEVERAGING HARMONIZED POPULATION-WIDE REAL-WORLD DATA FROM HEALTH REGISTRIES AND BIOBANKS

European Neuropsychopharmacology

While recent genome-wide association studies (GWAS) have shown that antidepressant response has a genetic component, the robust identification of genetic associations in current st

SEP 21, 2026 · JOURNAL ARTICLE

70. MULTI-PGS BASED CHARACTERIZATION OF BIPOLAR DISORDER CLINICAL AND GENETIC SUBTYPES USING A NOVEL COMBINATION OF SEMI-SUPERVISED AND UNSUPERVISED LEARNING

European Neuropsychopharmacology

Background Bipolar disorder (BIP) is a highly heritable and severe mental disorder characterized by depressive and manic (Type I) or hypomanic episodes (Type II). While GWAS of BIP

SEP 21, 2026 · JOURNAL ARTICLE

A FAMILY FOCUSED APPROACH IN ADULT AND CHILD AND YOUTH MENTAL HEALTH SERVICES

European Neuropsychopharmacology

Given the heritability of mental disorders it is not surprising that prevalence rates for mental disorders are increased in children of parents with mental illness as well as in pa